18F-DOPA PET/CT and neuroendocrine tumours

Eur J Nucl Med Mol Imaging. 2006 May;33(5):509-13. doi: 10.1007/s00259-006-0079-5.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Dihydroxyphenylalanine / analogs & derivatives*
  • Fluorodeoxyglucose F18*
  • Humans
  • Neuroendocrine Tumors / diagnostic imaging*
  • Positron-Emission Tomography / methods*
  • Practice Guidelines as Topic
  • Practice Patterns, Physicians' / trends
  • Radiopharmaceuticals
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Subtraction Technique*
  • Tomography, X-Ray Computed / methods*

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18
  • fluorodopa F 18
  • Dihydroxyphenylalanine